| 摘要 |
The present invention discloses and claims: (i) compositions, methods, and kits which lead to an increase in patient survival time in cancer patients receiving chemotherapy; (ii) compositions and methods which cause cytotoxic or apoptotic poten-tiation of the anti-cancer activity of chemotherapeutic agents; (iii) compositions and methods for maintaining or stimulating hema-tological function in patients in need thereof, including those patients suffering from cancer; (iv) compositions and methods for maintaining or stimulating erythropoietin function or synthesis in patients in need thereof, including those patients suffering from cancer; (v) compositions and methods for mitigating or preventing anemia in patients in need thereof, including those patients suf-fering from cancer; (vi) compositions and methods for maintaining or stimulating pluripotent, multipotent, and unipotent normal stem cell function or synthesis in patients in need thereof, including those patients suffering from cancer; (vii) compositions and methods which promote the arrest or retardation of tumor progression in those cancer patients receiving chemotherapy; (viii) com-positions and methods for increasing patient survival and/or delaying tumor progression while maintaining or improving the quali-ty of life in a cancer patient receiving chemotherapy; (ix) novel methods of the administration of taxane and/or platinum medica-ments and a Formula (I) compound of the present invention to a cancer patient; and (x) kits to achieve one or more of the afore-mentioned physiological effects in a patient in need thereof, including those patients suffering from cancer.
|
